MAPT and Alzheimer disease: Saliva concentrations of neurodegenerative disease biomarkers such as total tau (t-tau) and neurofilament light chain protein (NfL) are not disease specific for AD and do not correlate to plasma AD biomarkers (Ashton, 2018)(Gleerup, 2021).